Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05916222 · ClinicalTrials.gov registry record · NA
The Effects of Caregiver Training on DTTC Treatment Outcomes in CAS
A NA study of Childhood Apraxia of Speech, sponsored by New York University.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 2
- Study locations
NCT05916222: Recruiting NA study of Childhood Apraxia of Speech, sponsored by New York University.
NCT05916222 is a NA study of Childhood Apraxia of Speech that is actively recruiting participants, run by New York University. The registered enrollment target is 40 participants, below the 184-participant average among 3 other Childhood Apraxia of Speech trials with a reported enrollment target (78% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05916222, a NA study of Childhood Apraxia of Speech, is actively recruiting participants, sponsored by New York University.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of this clinical trial is to investigate the impact of direct vs. indirect caregiver training on treatment outcomes following a period of Dynamic Temporal and Tactile Cueing (DTTC) intervention combined with home practice in childhood apraxia of speech (CAS). Forty children with CAS, between the ages of 2;5 and 7;11 years of age, will be recruited for this study. All children will receive DTTC treatment at the frequency of standard care (2x/week) in a university clinic over and 8-week period. Participants will be randomly assigned to one of two groups: the Direct Training Group; the Indirect Training Group. All caregivers will complete an educational module about CAS, will observe all sessions, and will engage in home practice with their children. Caregivers in the Direct Group will receive coaching in the use of DTTC with their child during a portion of each treatment session to support home practice, whereas those in the Indirect Group will not receive detailed guidance for home practice. Caregivers in both groups will practice at home with their children during the treatment phase (3x/week). Following the treatment phase, home practice will continue at a higher frequency (6x/week) during a 4-week follow-up phase. Treatment outcomes will be compared between groups.
Primary Outcome
A multi-factor whole-word accuracy measure (Multilevel word Accuracy Composite Scale (MACS); Case et al., in press) of segmental accuracy, word shape maintenance, prosodic accuracy, and smoothness/fluency of movement transitions will be calculated for treated and generalization words. A MACS score ranges from 0 (all inaccurate) to 1.0 (all accurate). The higher the MACS score is to 1, the more accurate the production would be for that word. Judgments of word accuracy will be made by anonymous ra
Conditions Studied
Interventions
- BEHAVIORAL Dynamic Temporal and Tactile Cueing (DTTC)
Study Locations (2)
New York
- Hofstra University - Hempstead
- New York University - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2023-07-19 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What NCT05916222 shows while recruiting
NCT05916222 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 184-participant average among 3 other Childhood Apraxia of Speech trials with a reported enrollment target (78% lower).
The record links to 1 condition, with Childhood Apraxia of Speech appearing as the primary indexed condition, and to 1 intervention - of which Dynamic Temporal and Tactile Cueing (DTTC) is the first listed.
NCT05916222 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT05916222 about?
NCT05916222 is a clinical study titled "The Effects of Caregiver Training on DTTC Treatment Outcomes in CAS". The goal of this clinical trial is to investigate the impact of direct vs. indirect caregiver training on treatment outcomes following a period of Dynamic Temporal and Tactile Cueing (DTTC) intervention combined with home practice in childhood apraxia of speech (CAS). Forty children with CAS, betwee...
What is the current status of trial NCT05916222?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2023-07-19. Estimated completion is 2026-12-31.
What conditions does trial NCT05916222 study?
This clinical trial studies the following conditions: Childhood Apraxia of Speech.
What interventions are being tested in trial NCT05916222?
The interventions under investigation include: Dynamic Temporal and Tactile Cueing (DTTC) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05916222?
This trial is sponsored by New York University, which has 83 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05916222 being conducted?
This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Childhood Apraxia of Speech
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI